Mineralys Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
MLYS
CUSIP
603170101
Type
Equity
Class
COM
Num filings
4
Total reported value, excl. options
$44.9 k
Manager Report Date Value ($000) Shares Option Type